Lipid Metabolism
Showing 1 - 25 of >10,000
Metabolism Disorder, Glucose, Metabolism Disorder, Lipid, Vitiligo Trial in Xi'an (Collecting blood samples)
Completed
- Metabolism Disorder, Glucose
- +2 more
- Collecting blood samples
-
Xi'an, Shaanxi, ChinaXijing Hospital
Jul 21, 2023
Metabolism Trial in Austin (12 hours of physical inactivity, 24 hours of physical inactivity, 36 hours of physical inactivity)
Not yet recruiting
- Metabolism
- 12 hours of physical inactivity
- +2 more
-
Austin, TexasThe University of Texas at Austin
Sep 13, 2023
Metabolic & Bariatric Surgery on Lipid Metabolism,
Not yet recruiting
- Obesity
- Metabolic & Bariatric Surgery
- (no location specified)
Sep 22, 2023
HIV Infection, Combined Antiretroviral Therapy Trial in Hangzhou
Recruiting
- HIV Infection
- Combined Antiretroviral Therapy
-
Hangzhou, Zhejiang, ChinaZhikai Wan
Aug 30, 2023
Nutrition, Healthy, Dietary Deficiency, Bone Resorption Trial in Palermo (Control Group, Biostimulated group)
Completed
- Nutrition, Healthy
- +5 more
- Control Group
- Biostimulated group
-
Palermo, ItalyNABbio, STEBICEF department
Jul 30, 2023
Type 2 Diabetes, Lipid Metabolism Disorder, Fatty Acid Metabolism Disorder Trial in Lianshui (omega-3 polyunsaturated fatty
Completed
- Type 2 Diabetes Mellitus
- +2 more
- omega-3 polyunsaturated fatty acids
- corn oil
-
Lianshui, Jiangsu, ChinaLian Shui People's Hospital
Oct 2, 2023
Hypercholesterolemia Trial in Guanzhou (Swisse plus cholesterol capsule, Placebo)
Not yet recruiting
- Hypercholesterolemia
- Swisse plus cholesterol capsule
- Placebo
-
Guanzhou, Guangdong, ChinaSunYat-senU
Apr 28, 2023
The Genetic, Protein, and Lipid Basis of Variation in
Active, not recruiting
- Lipid Metabolism Disorders
-
Dallas, TexasUT Southwestern Medical Center
Dec 21, 2022
Glucose Metabolism Disorders (Including Diabetes), Lipid Metabolism Disorders, Appetitive Behavior Trial in Loughborough (Acute
Recruiting
- Glucose Metabolism Disorders (Including Diabetes Mellitus)
- +2 more
- Acute oral CBD supplementation
- Acute oral placebo supplementation
-
Loughborough, Leicestershire, United KingdomLoughborough University
Jan 16, 2023
The Atherogenic Index of Plasma(AIP) in Atrial Fibrillation
Not yet recruiting
- Atrium; Fibrillation
- +3 more
- (no location specified)
Jul 25, 2023
Exclusive Breastfeeding Improves Puerperal Glucose Metabolism in
Completed
- Gestational Diabetes
- +2 more
- observe
-
Nanjing, Jiangsu, ChinaNanjing Maternal and child Health Care Hospital
Nov 27, 2022
Liver Fat, Cardiac Function, Lipid Disorder Trial in Oxford (Diet)
Recruiting
- Liver Fat
- +3 more
- Diet
-
Oxford, United KingdomOxford Centre for Diabetes, Endocrinology and Metabolism
Jul 18, 2023
Lipid Metabolism Disorder Trial (Implementation Strategy Bundle, Usual care notification)
Not yet recruiting
- Lipid Metabolism Disorder
- Implementation Strategy Bundle
- Usual care notification
- (no location specified)
Jan 11, 2023
Obesity Trial in Karachi (Exercise)
Completed
- Obesity
- Exercise
-
Karachi, Sindh, PakistanZiauddin University
Nov 1, 2023
Cardiometabolic Syndrome, Glucose Metabolism Disorders, Blood Pressure Trial in Olsztyn (Dietary)
Recruiting
- Cardiometabolic Syndrome
- +3 more
- Dietary
-
Olsztyn, PolandUniversity of Warmia and Mazury in Olsztyn
Mar 7, 2023
Schizophrenia, Treatment-resistant Schizophrenia, Side Effect Trial (Aripiprazole, Paliperidone)
Not yet recruiting
- Schizophrenia
- +6 more
- (no location specified)
Sep 27, 2023
Lipid Disorder Trial in Winston-Salem (moderate- or high-intensity statin/ rosuvastatin)
Not yet recruiting
- Lipid Disorder
- moderate- or high-intensity statin/ rosuvastatin
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Feb 15, 2023
Morning Versus Afternoon Aerobic Exercise in Type 1 Diabetes
Not yet recruiting
- Type1diabetes
- Morning exercise
- Afternoon exercise
- (no location specified)
Nov 2, 2023
Hypercholesterolemia, Cardiovascular Risk Factor, Dyslipidemias Trial in Clermont-Ferrand (TOTUM-070)
Recruiting
- Hypercholesterolemia
- +4 more
- TOTUM-070
-
Clermont-Ferrand, FranceCIC Clermont Ferrand
Oct 25, 2022
Normal and Overweight Individuals at High-risk of Diabetes Trial in Pittsburgh (Fasting arm, Weight maintenance, Counseling)
Not yet recruiting
- Normal and Overweight Individuals at High-risk of Diabetes
- Fasting arm
- +2 more
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Feb 10, 2023
Glucagon-Like Peptide-1 Receptor, Metformin, Obesity, Abdominal Trial in Shanghai (Liraglutide, Semaglutide, Metformin)
Recruiting
- Glucagon-Like Peptide-1 Receptor
- +7 more
- Liraglutide
- +2 more
-
Shanghai, Shanghai, ChinaRen Ji Hospital, Shanghai Jiao Tong University School of Medicin
Mar 9, 2023
Chronic Kidney Diseases, Dialysis; Complications, Inflammation Trial in Florianópolis (flaxseed oil and pomegranate dry extract,
Completed
- Chronic Kidney Diseases
- +3 more
- flaxseed oil and pomegranate dry extract
- sunflower oil and microcrystalline cellulose
-
Florianópolis, Santa Catarina, BrazilFederal University of Santa Catarina
Sep 30, 2022
Lipid Disorder, Premature Myocardial Infarction Trial in Harbin (No intervention)
Enrolling by invitation
- Lipid Disorder
- Premature Myocardial Infarction
- No intervention
-
Harbin, Heilongjiang, Chinathe first affiliated hospital of Harbin medical university
Dec 2, 2022
Type 2 Diabetes, Arteriosclerosis, Arterial Hypertension Trial in Berlin (PräVaNet-Intervention)
Active, not recruiting
- Type 2 Diabetes
- +3 more
- PräVaNet-Intervention
-
Berlin, GermanyDeutsches Herzzentrum der Charité; Department of Cardiology, Ang
Jun 5, 2023